Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiskias G. Keizer is active.

Publication


Featured researches published by Hiskias G. Keizer.


Journal of Medicinal Chemistry | 2004

Synthesis, biological properties, and molecular modeling investigations of novel 3,4-diarylpyrazolines as potent and selective CB1 cannabinoid receptor antagonists

Jos H.M. Lange; Hein K. A. C. Coolen; Herman H. van Stuivenberg; Jessica A. R. Dijksman; A.H.J. Herremans; Eric Ronken; Hiskias G. Keizer; Koos Tipker; Andrew C. McCreary; Willem Veerman; Henri C. Wals; Bob Stork; Peter C. Verveer; Arnold P. den Hartog; Natasja M.J de Jong; Tiny J.P. Adolfs; Jan Hoogendoorn; Chris G. Kruse


Journal of Medicinal Chemistry | 2005

Bioisosteric Replacements of the Pyrazole Moiety of Rimonabant: Synthesis, Biological Properties, and Molecular Modeling Investigations of Thiazoles, Triazoles, and Imidazoles as Potent and Selective CB1 Cannabinoid Receptor Antagonists

Jos H.M. Lange; Herman H. van Stuivenberg; Hein K. A. C. Coolen; Tiny J.P. Adolfs; Andrew C. McCreary; Hiskias G. Keizer; Henri C. Wals; Willem Veerman; Alice J. M. Borst; Wouter de Looff; Peter C. Verveer; Chris G. Kruse


Journal of Medicinal Chemistry | 2005

Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[ω-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition

Pieter Smid; Hein K. A. C. Coolen; Hiskias G. Keizer; Rolf van Hes; Janpeter de Moes; Arnold P. den Hartog; Bob Stork; Rob H. Plekkenpol; Leonarda C. Niemann; Cees Stroomer; Martin Tulp; Herman H. van Stuivenberg; Andrew C. McCreary; Mayke B. Hesselink; and Arnoud H. J. Herremans; Chris G. Kruse


Journal of Medicinal Chemistry | 2011

N′-(Arylsulfonyl)pyrazoline-1-carboxamidines as Novel, Neutral 5-Hydroxytryptamine 6 Receptor (5-HT6R) Antagonists with Unique Structural Features

Arnold van Loevezijn; Jennifer Venhorst; Wouter I. Iwema Bakker; Cor G. de Korte; Wouter de Looff; Stefan Verhoog; Jan-Willem van Wees; Martijn van Hoeve; Rob P. van de Woestijne; Martina A.W. van der Neut; Alice J. M. Borst; Maria J.P. van Dongen; Natasja M.W.J. de Bruin; Hiskias G. Keizer; Chris G. Kruse


Bioorganic & Medicinal Chemistry Letters | 2008

7-Azaindole derivatives as potential partial nicotinic agonists.

Axel Stoit; Arnold P. den Hartog; Harry Mons; Sjoerd van Schaik; Nynke Barkhuijsen; Cees Stroomer; Hein K. A. C. Coolen; Jan Hendrik Reinders; Tiny J.P. Adolfs; Martina A.W. van der Neut; Hiskias G. Keizer; Chris G. Kruse


Archive | 2007

Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists

Arnold van Loevezijn; Wouter I. Iwema Bakker; Hiskias G. Keizer; Jan Zorgdrager; Martina A.W. van der Neut; Cornelis G. Kruse


Archive | 2004

1h-imidazole derivatives as cannabinoid receptor modulators

Josephus H. M. Lange; Cornelis G. Kruse; Herman H. van Stuivenberg; Hiskias G. Keizer


Archive | 2003

Neurotensin active 2,3,diaryl-pyrazolidine derivatives

Roelof W. Feenstra; Josephus H. M. Lange; Maria L. Pras-Raves; Cornelis G. Kruse; Herman H. van Stuivenberg; Tinka Tuinstra; Hiskias G. Keizer


Archive | 2007

1 H-IMIDAZOLE DERIVATIVES AS CANNABINOID RECEPTOR MODULATORS

Josephus H. M. Lange; Cornelis G. Kruse; Herman H. van Stuivenberg; Hiskias G. Keizer


Archive | 2006

[1,2,4]-Dithiazoli(di)ne derivatives, inducers of gluthathione-S-transferase and NADPH quinone oxido-reductase, for prophylaxis and treatment of adverse conditions associated with cytotoxicity in general and apoptosis in particular

Roelof W. Feenstra; Hiskias G. Keizer; Maria L. Pras-Raves; Bernard J. Van Vliet; Gustaaf J. M. Van Scharrenburg

Researchain Logo
Decentralizing Knowledge